Skip to content

A Comparative Study of Clonidine and Magnesium sulfate Premedication on peri operative hormonal stress responses, hemodynamic stability and postoperative analgesia in Laparoscopic Cholecystectomy

A comparative study of clonidine and magnesium sulfate premedication on peri operative hormonal stress responses, hemodynamic stability and postoperative analgesia in patients with gallbladder diseases undergoing laparoscopic cholecystectomy: A randomized, double-blind, controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616001233415
Acronym
C . Vs. Mgso4 in LC
Enrollment
105
Registered
2016-09-05
Start date
2016-01-10
Completion date
2017-01-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We will compare preoperative administration of I.V. clonidine and magnesium sulphate in laparoscopic cholecystectomy on stress hormones( cortisol and ACTH levels) , hemdynamic stability and post operative analgesia.

Interventions

3 groups are included in which a total volume of 50 ml . Isotonic saline (0.9%) are given slow intravenous (I.v) infusion over 15 minutes before induction of general anesthesia Group 1: received 1.5 ug/kg of clonidine in the infusion regimen Group 2: received 30 mg/kg of Magnesium sulfate in the infusion Group 3: received saline only(placebo group) infusion of 50 ml. saline

Sponsors

South valley university
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

American society of A nesthesiologists( ASA) I and II, patients with gallbladder diseases subjected for elective laparoscopic cholecystectomy( LC) .

Exclusion criteria

Patients with cardiovascular,respiratory,renal, hepatic or neurological diseases, diabetes mellitus, pregnancy or breast feeding females, morbidly obese patients, endocrine disorders,prolonged procedures ( more than 120 minutes), patients on anti hypertensives, antipsychotics, analgesics or sedative medications

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026